中国药学杂志
    
           首页  |  期刊介绍  |  编 委 会  |  投稿指南  |  期刊订阅  |  广告服务  |  会议信息  |  联系我们  | 
�й�ҩѧ��־ 2013, Vol. 48 Issue (13) :1041-1043    DOI: 10.11669/cpj.2013.13.001
�� �� ����Ŀ¼ | ����Ŀ¼ | ������� | �߼����� << | >>
�������˷�����Ч�۲ⶨ�����Ƚϼ���չ���Ʒ���
����ϼ,����,����,̷�Ǿ�,������*
�й�ʳƷҩƷ�춨�о�Ժ�ٰ��������붾����,���������\����Ʒ�춨���������׼���ص�ʵ����,���� 100050
DONG Guo-xia, MA Xiao, TIAN Lin, TAN Ya-jun, HOU Qi-ming*
Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, National Institute of Food and Drug Control, Beijing 100050, China

Download: PDF (507KB)   HTML (1KB)   Export: BibTeX or EndNote (RIS)      Supporting Info
ժҪ Ŀ�� �˽�Ŀǰ�������˷�����Ч�۲ⶨ���õķ��������µ��о���չ���䷢չ���ơ����� ��Ҫ���й���ŷ�ޡ�Ӣ�����ձ���ӡ��ҩ�䡢WHO�ٰ���������������ָ�ϡ��������õķ���������������������Ϊ����,���й��ɡ��ܽ�ͷ������������� �������˷�����Ч�۲ⶨ�����ڲ��õĽ�����������ȫ������������ڼ��,������ط�����о��Ѿ���Ϊ����֮����
Service
�ѱ����Ƽ�������
�����ҵ����
�������ù�����
Email Alert
RSS
�����������
����ϼ
����
����
̷�Ǿ�
������*
�ؼ����� �������˷�����   Ч��   �ⶨ�����Ƚ�   ��չ���Ʒ���     
Abstract�� Objective To get the present information of potency assay Methods of adsorbed tetanus vaccine, latest research and developmental trend.Methods Induction, summary and analyses were used, mainly according to the Chinese Pharmacopoeia, European Pharmacopoeia, British Pharmacopoeia, Japanese Pharmacopoeia, Indian Pharmacopoeia, the manual for quality control of diphtheria, tetanus, and pertussis vaccines, adopted Methods of FDA and literatures in the field. Results and Conclusion In the near future, complete in vitro potency assay Methods of adsorbed tetanus vaccine can be used instead of in vivo assay, so it is important and urgent that related research should be made in China.
Keywords�� adsorbed tetanus vaccine,   potency,   assay method comparison,   developmental trend analyses     
�ո�����: 2012-12-14;
ͨѶ���� ������,Ů,�о�Ա �о����������������� Tel/Fax(010)67095355 E-mailhouqiming@sina.com     Email: houqiming@sina.com
���߼��: ����ϼ,Ů,��ʿ �о�����������������
���ñ���:   
����ϼ, ����, ���ص� .�������˷�����Ч�۲ⶨ�����Ƚϼ���չ���Ʒ���[J]  �й�ҩѧ��־, 2013,V48(13): 1041-1043
DONG Guo-Xia, MA Xiao, TIAN Lin etc .Comparison and Development Trend Analysis of Potency Test Methods of Adsorbed Tetanus Vaccine[J]  Chinese Pharmaceutical Journal, 2013,V48(13): 1041-1043
��
[1] GALAZKA A, COOK R. Neonatal tetanus today and tomorrow//Nistico G, Mastroeni P, Pitzurra M. Proceeding of the Seventh International Conference on Tetanus. Rome: Gangeni, 1985: 350-363.
[2] REY M, TIKHOMIROV E. Non neonatal tetanus over the world// Nistico G, Bizzini B, Bytchenko M, Triau R. Proceeding of the Eighth International Conference on Tetanus. Rome: Pythagoras, 1989: 506-518.
[3] Ch.P(2010)Vol��(�й�ҩ��2010���.����). 2010: 53-55, App 81.
[4] P Eu(7.0)(European Pharmacopoeia 7.0 Edition). 2011: 214-217.
[5] BP(2012)( British Pharmacopoeia 2012 Edition).2012: 404-409.
[6] JP(16)( Japanese Pharmacopoeia 16 Edition).2011:1479.
[7] National Institute of Infectious Disease. Japanese Minimum Requirements for Biological Products. 2006:107-111.
[8] IP(2010)(Indian Pharmacopoeia 2010 Edition). 2010: 2443-2447.
[9] WHO /IVB/11.11.Manual for Quality Control of Diphtheria, Tetanus and Pertussis Vaccines . 2013: 103-143.
[10] US Department of Health, Education and Welfare Public Health Service, National Institute of Health. Minimum Requirements: Tetanus Toxoid. Fourth Revision. Bethesda, MD, NIH, 1952:1-8.
[11] SESARDIC D, WINSNES R, RIGSBY P, et al. Calibration of replacement International Standard and European Pharmacopoeia biological reference preparation for tetanus toxoid, adsorbed. Biologicals, 2002, 30(1): 49-68.
[12] WHO Technical Report Series No 927, Recommendations for diphtheria, tetanus, pertussis and combined vaccines(Amendments 2003)-Annex 5. 2005: 138-147.
[13] WINSNES R, HENDRIKSEN C. Collaborative study for the validation of serological methods for potency testing of tetanus toxoid vaccines for human use-part1. Pharmeuropa Special Issue Bio, 2001: 83-124.
[14] HENDRIKSEN C, WINSNES R. Serological methods for potency testing of tetanus toxoid vaccines for human use. Dev Biol(Basel), 2002, 111:131-140.
[15] COPLU N, ESEN B, GOZALAN A, et al. Tetanus antibody assay combining in-house ELISA and particle agglutination test and its serosurvey application in a province in turkey. Jpn J Infect Dis, 2004, 57: 97-102.
[16] AGENAARS A M, VAN DELFT R W, NAGEL J. Comparison of ELISA and toxin neutralization for the determination of tetanus antibodies. J Immunoassay, 1884, 5:1-11.
[17] SIMONSEN O, BENTZON M W, HERON I. ELISA for routine determination of antitoxic immunity to tetanus. J Biol Stand, 1986, 14: 231-239.
[18] GERMAN F M, BIZZINI B, GERMAN A. Immunity to tetanus: Tetanus antitoxin and anti-B��b in human sera. J Biol Stand, 1987, 15: 223-230.
[19] HENDRIKSEN C, GUN J, NAGEL J, et al. The Toxin Binding Inhibition Test as a reliable in vitro alternative to the Toxin Neutralisation test in mice for the estimation of tetanus antitoxin in human sera. J Biol Stand, 1988, 16:287-297.
[20] HENDRIKSEN C, GUN J, MARSMAN F, et al. The use of the in vitro Toxin Binding Inhibition(ToBI) test for the estimation of the potency of tetanus toxoid. Biologicals, 1991, 19(1): 23-29.
[21] Ch.P(1995)Vol��(�й�ҩ��1995���.����). 1995: 232.
[22] Requirements for Biologics of PRC(1995) Vol��(�й�������Ʒ���1995��.һ��) . 1995: 157-159.
[23] Ch.P(2000)Vol��(�й�ҩ��2000���.����). 2000: 1101-1102.
[24] Requirements for Biologics of PRC(2000)(�й�������Ʒ���2000���). 2000: 213-218.
[25] Ch.P(2005)Vol��(�й�ҩ��2005���.����). 2005: 62-63, app 66.
[26] PRIEUR S, BROC S, GAL M, et al. Development of an in vitro potency test for tetanus vaccines an immunoassay based on Hc fragment determination. Dev Biol(Basel), 2002, 111: 37-46.
[27] SEATOVIC S, INIC′-KANADA, STOJANOVIC M, et al. Development of sandwich enzyme-linked immunosorbent assay for determination of tetanus toxoid concentration. J Immunoassay Immunochem, 2004, 25(1): 31-44.
[28] PIERSMA S J, LEENAARS M P, GUZYLACK P L, et al. An in vitro immune response model to determine tetanus toxoid antigen(vaccine) specific immunogenicity: Selection of sensitive assay criteria. Vaccine, 2006, 24(16): 3076-3083.
[29] LIU C Y, WANG S F, ZHANG Z L, et al. Comparision: Detection of Tetanus Antitox in by ELISA and Toxin Neutralization Test(TNT) . Chin J Biologicals(�й�������Ʒѧ��־), 1995, 8(4): 175-178.
Copyright 2010 by �й�ҩѧ��־